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INTRODUCTION
The association between fetal chromosomal abnormality
and increased nuchal translucency (NT) thickness during the
first trimester of pregnancy is well-established (1, 2). Such a
screening test may identify over 70% of trisomy 21 pregnan-
cies in the first trimester, with a 5% screen-positive rate (1, 2).
Even in a chromosomally normal fetus, the appearance of a
thickened NT during 11-14 weeks of gestation is also strong-
ly associated with fetal structural defects, genetic syndromes,
and poor perinatal outcomes (3-5).
In the first trimester of pregnancy, NT has been widely used
as a screening test for fetal Down syndrome either alone or in
combination with serum markers (6). It is well documented
that ethnic differences in biochemical markers levels exist both
in the first and second trimesters (7, 8). A recent report showed
that there was a small but significant difference in NT thick-
ness measurements between fetuses of different ethnic origins
(9). However, there have, up to now, been only limited data
of NT thickness in the first trimester for Korean population
(10-12). It is therefore important to establish normative data
for the distribution of NT thickness. Here we report our results
of ultrasound measurement of NT thickness in 2,577 normal
fetuses between 11 and 14 weeks of gestation in a Korean po-
pulation.
MATERIALS AND METHODS
The data were collected from pregnant women with single-
ton pregnancies in whom fetal ultrasound was performed and
the fetal NT thickness was measured between 11 and 14 weeks
of gestation at our institute during the period from January
2001 to December 2001. Pregnancy outcomes were reviewed
from the obstetric and neonatal records. Those cases with no
obstetrical or neonatal records were excluded from analysis.
Only cases with a known normal outcome which could be fo-
und in Samsung Cheil Hospital Obstetrics Database were in-
cluded. Cases affected by chromosomal and major structural
abnormalities and cases resulting in miscarriage or intrauter-
ine death were excluded from analysis.
The gestational age was calculated from the first day of the
last menstrual period and was confirmed by crown-rump length
measurement (13). In cases in which the estimated gestation-
al age by menstrual and ultrasound estimation were discrepant
for more than 7 days, the ultrasound estimation was used.
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The Distribution of Fetal Nuchal Translucency Thickness in Normal
Korean Fetuses
The aim of present study was to establish normative data for the distribution of nuchal
translucency (NT) thickness in normal Korean fetuses. The data were collected from
pregnant women with singleton pregnancies in whom fetal ultrasound was performed
and the fetal NT thickness was measured between 11 and 14 weeks of gestation.
Among them, a total of 2,577 fetuses with a known normal outcome were included
in this study. The distribution of multiple of median (MoM) values of the NT thickness
with crown-rump length (CRL) in 10-mm intervals and the 95th percentile of MoM
were calculated with the linear regression method. The present study showed that
NT measurements increase with increasing CRL and a false positive rate increases
with increasing gestational age. Therefore, a fixed cut-off point through the first tri-
mester was not appropriate and each NT measurement should be examined accord-
ing to the gestational age. The present study offers normative data of the fetal NT
thickness in a Korean population, which can be used as reference for screening chro-
mosomal aberrations or other congenital abnormalities in the first trimester.
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Fetal NT thickness was measured using transabdominal or
transvaginal sonography (HDI 3000, ATL, Bothell, WA, U.
S.A.) in a good mid-sagittal section of the fetus with magni-
fication so that the fetus occupied at least 75% of the image.
The NT was defined as the black area between the inner skin
outlines echo and the outer border of the soft tissue overlying
the cervical spine. The maximal thickness of the black area was
measured with caliper placed on the lines (representing the
nuchal skin and the underlying soft tissue) to 0.1 mm when
the sagittal section of the fetuses was obtained (Fig. 1). At the
same time, the fetal crown-rump length (CRL) was measured.
Cystic hygroma was defined as a sonolucent area consisting of
two systemic cavities completely separated by a midline sep-
tum, irrespective of size (14). These cases were excluded from
the study. Care was taken not to take a measurement with the
fetus overextended because an extended fetal neck will result
in a falsely increased measurement (15). Care was also taken
to distinguish between the fetal skin and the amniotic mem-
brane. If it was impossible to obtain a proper image of the fetal
nuchal translucency due to fetal position, we waited for spon-
taneous fetal movement away from the amniotic membrane;
alternatively, the fetus was bounced off amnion by asking the
mother to cough and/or tapping the maternal abdomen. In
such cases it was helpful to use the cineloop function (a func-
tion that permits the replay of ultrasound images taken in the
past few seconds) to visualize the fetus in a satisfactory posi-
tion. At least three measurements were taken during the scan
and the largest was recorded.
In order to establish normative data of NT thickness, the
relationship between fetal NT thickness and CRL was analyzed
with the linear regression method. According to the regres-
sion equation, the expected the 5th, 50th, and 95th percentile
values of NT thickness were obtained for a given CRL.
All the cases were subdivided into five categories by the
CRL of the fetuses with 10-mm intervals. To correct for the
gestational effect, the median value of NT thickness in each
CRL category was calculated and then all the measurements
of NT thickness were converted to multiple of median (MoM)
values.
Statistical analysis was performed by Statistics Package for
Social Science (SPSS) 10.0 computer software. A p value of
<0.05 was considered statistically significant.
RESULTS
Between January and December 2001, a total of 2,577 preg-
nancies satisfied the above inclusion criteria and were includ-
ed for analysis. The mean maternal age was 29.94±3.28 yr
(range 19-44 yr). The mean CRL was 60.16±9.07 mm (range
40.0-92.0 mm), the mean NT thickness was 1.62±0.50 mm
(range 0.5-5.0 mm), respectively. The median gestational age
was 12.5 weeks.
Fig. 2 plots the distribution and the 5% and 95%, lower
and upper limits of NT thickness according to the simple lin-
ear regression. NT thickness increased with CRL estimates
of gestational age. The regression equation relating median
Fig. 1. Measurement of the nuchal translucency (NT) thickness on
transvaginal ultrasound scan in 12.0 weeks sized fetus.
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Fig. 2. The distribution of nuchal translucency (NT) thickness in
normal fetuses with crown-rump length.
CRL (mm)
Expected nuchal translucency (mm)
5th percentile 50th percentile 95th percentile
40 0.31 1.22 2.14
45 0.40 1.32 2.24
50 0.50 1.42 2.34
55 0.60 1.52 2.44
60 0.70 1.62 2.54
65 0.80 1.72 2.64
70 0.90 1.82 2.73
75 0.99 1.91 2.83
80 1.09 2.01 2.93
85 1.19 2.11 3.03
Table 1. The expected 5th, 50th, and 95th percentile values of
nuchal translucency (NT) with crown-rump length (CRL)34 J.-H. Chung, J.-H. Yang, M.-J. Song, et al.
NT thickness to CRL was described as follows: expected NT
thickness (mm)=0.437+0.01969×CRL (mm) (R2=0.127,
p<0.001).
The expected 5th, 50th, and 95th percentile values of NT
thickness to CRL are listed in Table 1. The median NT thick-
ness increased from 1.22 mm when the CRL measurement
was 40 mm to 2.11 mm with 85 mm sized CRL.
Table 2 shows the distribution of the NT thickness with
10-mm intervals of CRL. The mean NT MoM value to 10-
mm intervals of CRL was 0.998±0.298, and the 95th per-
centile of NT MoM was 1.50.
Table 3 shows the distribution of the NT thickness with
gestational age.
The incidence of NT thickness greater than or equal to 2.5
mm was increased; 2.2% in fetuses at 11.0-11.9 weeks of ges-
tation to 12.5% in fetuses at 14.0-14.9 weeks. One-hundred
and three out of the 2,577 fetuses (4.0%) had NT thickness
greater than or equal to 2.5 mm.
DISCUSSION
Our results demonstrate that fetal NT thickness increases
with CRL and are compatible with those of previous reports
(4, 16, 17). Therefore, in screening for chromosomal defects,
the use for a fixed cut-off in fetal NT thickness is inappropri-
ate, and each measurement should be examined according to
the CRL (18). Schuchter et al. have used MoM values to express
the relationship between NT measurement and gestational
age (19). This method is similar to that of biochemical mark-
ers used in second-trimester Down screening (20). Other stud-
ies asserted that the more accepted method is to base the cut-
off on a progressive rise, using 95th percentile as the thresh-
old for an abnormal NT thickness, resulting in a more sen-
sitive and specific indicator for the detection of anomalous
fetuses (21). Therefore, it is mandatory to establish the nor-
mative distribution of fetal NT measurement.
Several studies have been reported on the value of NT thick-
ness in the first trimester in Korean population (22-24). These
studies, however, are limited as they used a fixed cut-off in
fetal NT thickness. More recently, several other studies have
been reported in Korean literature (10-12), but they have rel-
atively small sample size. The present study includes a very
large number of pregnant women for analysis and thus offers
normative data of the fetal NT thickness in a Korean popula-
tion. Compared with the recent study by Jou et al. (25), which
measured the NT thickness from 897 Taiwanese pregnancies
between 9-14 gestational weeks, our results was similar to those.
There is a controversy as to the need to take the ethnic dif-
ference into account in the interpretation of NT measurements.
Jou et al. suggested that, given the small but statistically sig-
nificant differences, race-specific normative data should be
used (25). Other authors concluded that it is acceptable to use
a single standard, because screen positive rates in different
groups are similar (9, 26). In our study, the mean NT thick-
ness in normal Korean fetuses was 1.62 mm. Compared to
the study in Taiwanese population by Jou et al. (25), mean
NT thickness in our result was smaller than those by 0.1 mm.
Otherwise, compared with the study in Caucasians by Thi-
laganathan et al. (9), the difference was rather small (0.08
mm). Therefore, we suggest that the ethnic difference is not
significant in interpretation of NT measurements.
In our study, the incidence of NT thickness greater than or
equal to 2.5 mm was 4.0%. This observation is in accordance
with previous studies (2, 17). Scott et al. reported that the
incidence of NT thickness greater than or equal to 2.5 mm in
normal fetuses increased; 1.3% at CRL 30-39 mm to 13.2%
at CRL 60-69 mm (17). In our study, the incidence of NT
thickness greater than or equal to 2.5 mm in normal fetuses
was 2.2% at 11.0-11.9 weeks of gestation and increased to
12.5% at 14.0-14.9 weeks. Therefore, we confirm that a false
positive rate increases with increasing gestational age, and each
NT measurement should be examined according to the ges-
Gestational
age (weeks)
NT≥2.5 mm
No. %
No. %
11.0-11.9 554 21.5 12 2.2
12.0-12.9 1,402 54.4 51 3.6
13.0-13.9 565 21.9 33 5.8
14.0-14.9 56 2.2 7 12.5
Total 2,577 100 103 4.0
Table 3. The distribution of nuchal translucency (NT) measure-
ment in normal fetuses based on the gestational age 
CRL (mm) No. %
NT (mm)
Mean±SD Median Mean MoM±SD 1.50 MoM
40-49 324 12.6 1.32±0.44 1.2 1.10±0.37 1.80
50-59 921 35.7 1.51±0.47 1.5 1.01±0.31 2.25
60-69 923 35.8 1.73±0.47 1.8 0.96±0.26 2.70
70-79 353 13.7 1.85±0.50 1.9 0.98±0.26 2.85
≥80 56 2.2 2.02±0.50 2.0 1.01±0.25 3.00
Total 2,577 100 1.62±0.50 1.6 0.99±0.29 2.40
NT, nuchal translucency; MoM, multiples of median.
Table 2. The results of the five categories based on crown-rump length (CRL) in 10-mm intervalsNuchal Translucency in a Korean Population 35
tational age for screening of chromosomal abnormalities.
More recently, a new ultrasound marker has been described;
the nasal bone at 11 to 14 weeks was found to be absent in
about 70% of fetuses with trisomy 21 and in 0.5% of chro-
mosomally normal fetuses. It was estimated that screening
for trisomy 21 by a combination of maternal age, fetal NT
thickness, and examination of the nasal bone could increase
the detection rate to 85% whilst decreasing the false-positive
rate to 1% (27). Also, Cicero et al. reported that integrated
sonographic (fetal NT thickness and nasal bone) and biochem-
ical test using maternal serum free  -hCG and pregnancy-asso-
ciated plasma protein-A (PAPPA) at 11-14 gestational weeks
can potentially identify about 90% of trisomy 21 fetuses for
a false-positive rate of 0.5% (28). We are planning to inves-
tigate the diagnostic application of these integrated approach
in Korean fetuses at 11-14 gestational weeks to screen of tri-
somy 21 in the near future.
The present study offers normative data of the fetal NT
thickness in a Korean population, which can be used as ref-
erence for screening chromosomal aberrations or other con-
genital abnormalities and may be very helpful in establish-
ing the screening for Down syndrome in the first trimester
in Korea. As a false positive rate increases with increasing
gestational age, NT measurement should be adjusted accord-
ing to the gestational age for screening of chromosomal abnor-
malities.
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